Investigational Site Number : 1560044

Huizhou 516001

1 studies enrolling now · 1 studies all time

What they study most

Chronic Obstructive Pulmonary Disease

Studies at this site

• Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype — Recruiting now